Biogen Inc. (BIIB)
USD 146.79
(-2.56%)
USD 146.79
(-2.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 6.28 Billion USD | 96.84% |
| 2022 | 3.19 Billion USD | -40.2% |
| 2021 | 5.34 Billion USD | -17.78% |
| 2020 | 6.49 Billion USD | 88.11% |
| 2019 | 3.45 Billion USD | -26.7% |
| 2018 | 4.71 Billion USD | 8.04% |
| 2017 | 4.36 Billion USD | 4.18% |
| 2016 | 4.18 Billion USD | -19.7% |
| 2015 | 5.21 Billion USD | 941.26% |
| 2014 | -619.72 Million USD | -9240.27% |
| 2013 | -6.63 Million USD | -101.16% |
| 2012 | 570.05 Million USD | 3.73% |
| 2011 | 549.55 Million USD | 23.79% |
| 2010 | 443.93 Million USD | -14.31% |
| 2009 | 518.08 Million USD | 5.58% |
| 2008 | 490.71 Million USD | -45.68% |
| 2007 | 903.31 Million USD | 259.97% |
| 2006 | -564.68 Million USD | -7.62% |
| 2005 | -524.72 Million USD | -181.88% |
| 2004 | 640.86 Million USD | 11.96% |
| 2003 | 572.42 Million USD | 20434.64% |
| 2002 | -2.81 Million USD | -110.01% |
| 2001 | 28.11 Million USD | -53.59% |
| 2000 | 60.58 Million USD | 7.91% |
| 1999 | 56.14 Million USD | 54.22% |
| 1998 | 36.4 Million USD | 71.77% |
| 1997 | 21.19 Million USD | 399.95% |
| 1996 | 4.23 Million USD | 137.59% |
| 1995 | -11.27 Million USD | 79.38% |
| 1994 | -54.68 Million USD | 26.6% |
| 1993 | -74.5 Million USD | 13.27% |
| 1992 | -85.9 Million USD | -51.77% |
| 1991 | -56.6 Million USD | -349.21% |
| 1990 | -12.6 Million USD | 62.05% |
| 1989 | -33.2 Million USD | 32.93% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.94 Billion USD | -15.81% |
| 2024 Q1 | 5.87 Billion USD | -6.62% |
| 2024 Q3 | 3.2 Billion USD | 0.16% |
| 2023 Q3 | 5.42 Billion USD | 36.67% |
| 2023 Q2 | 3.97 Billion USD | 7.0% |
| 2023 Q1 | 3.71 Billion USD | 16.18% |
| 2023 FY | 6.28 Billion USD | 96.84% |
| 2023 Q4 | 6.28 Billion USD | 15.86% |
| 2022 Q2 | 4.9 Billion USD | -15.99% |
| 2022 FY | 3.19 Billion USD | -40.2% |
| 2022 Q4 | 3.19 Billion USD | 7.99% |
| 2022 Q3 | 2.95 Billion USD | -39.68% |
| 2022 Q1 | 5.83 Billion USD | 9.29% |
| 2021 FY | 5.34 Billion USD | -17.78% |
| 2021 Q2 | 5.89 Billion USD | -8.38% |
| 2021 Q1 | 6.42 Billion USD | -1.04% |
| 2021 Q4 | 5.34 Billion USD | -12.1% |
| 2021 Q3 | 6.07 Billion USD | 3.16% |
| 2020 Q3 | 5.6 Billion USD | 2.85% |
| 2020 Q1 | 3.77 Billion USD | 9.27% |
| 2020 FY | 6.49 Billion USD | 88.11% |
| 2020 Q2 | 5.45 Billion USD | 44.5% |
| 2020 Q4 | 6.49 Billion USD | 15.83% |
| 2019 Q4 | 3.45 Billion USD | -14.09% |
| 2019 Q1 | 4.13 Billion USD | -12.22% |
| 2019 Q2 | 4.64 Billion USD | 12.38% |
| 2019 Q3 | 4.02 Billion USD | -13.51% |
| 2019 FY | 3.45 Billion USD | -26.7% |
| 2018 Q1 | 1.82 Billion USD | -58.24% |
| 2018 Q4 | 4.71 Billion USD | 32.94% |
| 2018 Q3 | 3.54 Billion USD | -24.24% |
| 2018 FY | 4.71 Billion USD | 8.04% |
| 2018 Q2 | 4.67 Billion USD | 156.85% |
| 2017 Q3 | 4.39 Billion USD | -17.85% |
| 2017 FY | 4.36 Billion USD | 4.18% |
| 2017 Q1 | 5.59 Billion USD | 33.54% |
| 2017 Q4 | 4.36 Billion USD | -0.66% |
| 2017 Q2 | 5.34 Billion USD | -4.4% |
| 2016 Q4 | 4.18 Billion USD | -5.82% |
| 2016 Q1 | 5.4 Billion USD | 3.77% |
| 2016 Q2 | 5.18 Billion USD | -4.23% |
| 2016 Q3 | 4.44 Billion USD | -14.21% |
| 2016 FY | 4.18 Billion USD | -19.7% |
| 2015 FY | 5.21 Billion USD | 941.26% |
| 2015 Q1 | -894.12 Million USD | -44.28% |
| 2015 Q2 | -702.6 Million USD | 21.42% |
| 2015 Q3 | 2.44 Billion USD | 448.05% |
| 2015 Q4 | 5.21 Billion USD | 113.19% |
| 2014 Q4 | -619.72 Million USD | -3.45% |
| 2014 FY | -619.72 Million USD | -9240.27% |
| 2014 Q3 | -599.08 Million USD | -118.87% |
| 2014 Q2 | -273.72 Million USD | -16.95% |
| 2014 Q1 | -234.03 Million USD | -3427.34% |
| 2013 Q2 | 337.06 Million USD | 33.84% |
| 2013 Q1 | 251.84 Million USD | -55.82% |
| 2013 FY | -6.63 Million USD | -101.16% |
| 2013 Q4 | -6.63 Million USD | -102.45% |
| 2013 Q3 | 270.46 Million USD | -19.76% |
| 2012 Q4 | 570.05 Million USD | -13.62% |
| 2012 FY | 570.05 Million USD | 3.73% |
| 2012 Q2 | 637.8 Million USD | -18.36% |
| 2012 Q3 | 659.92 Million USD | 3.47% |
| 2012 Q1 | 781.23 Million USD | 42.16% |
| 2011 FY | 549.55 Million USD | 23.79% |
| 2011 Q3 | 488.92 Million USD | -1.71% |
| 2011 Q4 | 549.55 Million USD | 12.4% |
| 2011 Q2 | 497.44 Million USD | 21.41% |
| 2011 Q1 | 409.71 Million USD | -7.71% |
| 2010 Q1 | 455.75 Million USD | -12.03% |
| 2010 FY | 443.93 Million USD | -14.31% |
| 2010 Q3 | 453.31 Million USD | 26.32% |
| 2010 Q4 | 443.93 Million USD | -2.07% |
| 2010 Q2 | 358.85 Million USD | -21.26% |
| 2009 FY | 518.08 Million USD | 5.58% |
| 2009 Q4 | 518.08 Million USD | 0.5% |
| 2009 Q3 | 515.5 Million USD | 64.44% |
| 2009 Q2 | 313.5 Million USD | -9.21% |
| 2009 Q1 | 345.29 Million USD | -29.63% |
| 2008 Q4 | 490.71 Million USD | 1070.01% |
| 2008 FY | 490.71 Million USD | -45.68% |
| 2008 Q3 | 41.94 Million USD | -92.81% |
| 2008 Q2 | 583.13 Million USD | 51.55% |
| 2008 Q1 | 384.79 Million USD | -57.4% |
| 2007 Q4 | 903.31 Million USD | -19.56% |
| 2007 FY | 903.31 Million USD | 259.97% |
| 2007 Q1 | -719.74 Million USD | -27.46% |
| 2007 Q2 | -1.54 Billion USD | -115.12% |
| 2007 Q3 | 1.12 Billion USD | 172.52% |
| 2006 Q3 | -369.52 Million USD | -22.94% |
| 2006 Q4 | -564.68 Million USD | -52.82% |
| 2006 Q1 | -491.88 Million USD | 6.26% |
| 2006 FY | -564.68 Million USD | -7.62% |
| 2006 Q2 | -300.57 Million USD | 38.89% |
| 2005 Q2 | -595.99 Million USD | -204.56% |
| 2005 Q4 | -524.72 Million USD | -106.94% |
| 2005 Q1 | 569.99 Million USD | -11.06% |
| 2005 FY | -524.72 Million USD | -181.88% |
| 2005 Q3 | -253.56 Million USD | 57.45% |
| 2004 Q3 | 666.68 Million USD | 74.11% |
| 2004 FY | 640.86 Million USD | 11.96% |
| 2004 Q1 | 558.5 Million USD | -2.43% |
| 2004 Q2 | 382.91 Million USD | -31.44% |
| 2004 Q4 | 640.86 Million USD | -3.87% |
| 2003 FY | 572.42 Million USD | 20434.64% |
| 2003 Q2 | -22.29 Million USD | -205.4% |
| 2003 Q1 | 21.15 Million USD | 851.51% |
| 2003 Q3 | -75.31 Million USD | -237.76% |
| 2003 Q4 | 572.42 Million USD | 860.07% |
| 2002 FY | -2.81 Million USD | -110.01% |
| 2002 Q4 | -2.81 Million USD | -112.66% |
| 2002 Q3 | 22.23 Million USD | -52.38% |
| 2002 Q2 | 46.68 Million USD | 387.05% |
| 2002 Q1 | -16.26 Million USD | -157.84% |
| 2001 FY | 28.11 Million USD | -53.59% |
| 2001 Q4 | 28.11 Million USD | -33.75% |
| 2001 Q3 | 42.44 Million USD | 56.69% |
| 2001 Q2 | 27.08 Million USD | -64.11% |
| 2001 Q1 | 75.47 Million USD | 24.57% |
| 2000 FY | 60.58 Million USD | 7.91% |
| 2000 Q4 | 60.58 Million USD | 239.16% |
| 2000 Q3 | 17.86 Million USD | 238.0% |
| 2000 Q2 | -12.94 Million USD | 71.79% |
| 2000 Q1 | -45.88 Million USD | -181.73% |
| 1999 Q1 | -30.3 Million USD | -183.23% |
| 1999 FY | 56.14 Million USD | 54.22% |
| 1999 Q4 | 56.14 Million USD | 476.79% |
| 1999 Q3 | -14.9 Million USD | -322.39% |
| 1999 Q2 | 6.7 Million USD | 122.11% |
| 1998 Q1 | 23.6 Million USD | 11.36% |
| 1998 Q2 | 7.1 Million USD | -69.92% |
| 1998 Q3 | -11.9 Million USD | -267.61% |
| 1998 Q4 | 36.4 Million USD | 405.91% |
| 1998 FY | 36.4 Million USD | 71.77% |
| 1997 Q1 | -30.7 Million USD | -824.23% |
| 1997 FY | 21.19 Million USD | 399.95% |
| 1997 Q2 | -4.1 Million USD | 86.64% |
| 1997 Q3 | 5.8 Million USD | 241.46% |
| 1997 Q4 | 21.19 Million USD | 265.4% |
| 1996 Q2 | 2.6 Million USD | -71.43% |
| 1996 FY | 4.23 Million USD | 137.59% |
| 1996 Q1 | 9.1 Million USD | 180.7% |
| 1996 Q3 | -900 Thousand USD | -134.62% |
| 1996 Q4 | 4.23 Million USD | 571.0% |
| 1995 Q4 | -11.27 Million USD | 48.03% |
| 1995 Q3 | -21.7 Million USD | 0.0% |
| 1995 Q1 | -43.4 Million USD | 20.63% |
| 1995 FY | -11.27 Million USD | 79.38% |
| 1995 Q2 | -21.7 Million USD | 50.0% |
| 1994 Q3 | -65.5 Million USD | -67.52% |
| 1994 Q1 | -52.7 Million USD | 29.26% |
| 1994 Q2 | -39.1 Million USD | 25.81% |
| 1994 Q4 | -54.68 Million USD | 16.52% |
| 1994 FY | -54.68 Million USD | 26.6% |
| 1993 Q3 | -74.9 Million USD | 2.98% |
| 1993 Q2 | -77.2 Million USD | -62.87% |
| 1993 Q1 | -47.4 Million USD | 44.82% |
| 1993 FY | -74.5 Million USD | 13.27% |
| 1993 Q4 | -74.5 Million USD | 0.53% |
| 1992 Q3 | -75.4 Million USD | -104.89% |
| 1992 Q1 | -38.8 Million USD | 31.45% |
| 1992 Q4 | -85.9 Million USD | -13.93% |
| 1992 FY | -85.9 Million USD | -51.77% |
| 1992 Q2 | -36.8 Million USD | 5.15% |
| 1991 Q3 | -20.4 Million USD | -482.86% |
| 1991 Q4 | -56.6 Million USD | -177.45% |
| 1991 FY | -56.6 Million USD | -349.21% |
| 1991 Q1 | -17.1 Million USD | -35.71% |
| 1991 Q2 | -3.5 Million USD | 79.53% |
| 1990 FY | -12.6 Million USD | 62.05% |
| 1990 Q3 | -14.5 Million USD | 15.7% |
| 1990 Q4 | -12.6 Million USD | 13.1% |
| 1990 Q2 | -17.2 Million USD | -20.28% |
| 1990 Q1 | -14.3 Million USD | 56.93% |
| 1989 FY | -33.2 Million USD | 32.93% |
| 1989 Q4 | -33.2 Million USD | -2.79% |
| 1989 Q3 | -32.3 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Amgen Inc. | 53.66 Billion USD | 88.283% |
| AstraZeneca PLC | 22.78 Billion USD | 72.398% |
| Gilead Sciences, Inc. | 18.9 Billion USD | 66.732% |
| MIRA Pharmaceuticals, Inc. | -4.59 Million USD | 136876.36% |
| Scilex Holding Company | 124.54 Million USD | -4949.14% |
| Scilex Holding Company | 124.54 Million USD | -4949.14% |